Success Metrics

Clinical Success Rate
77.8%

Based on 7 completed trials

Completion Rate
78%(7/9)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
2(17%)

Phase Distribution

Ph phase_1
6
50%
Ph phase_2
4
33%
Ph phase_3
2
17%

Phase Distribution

6

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
6(50.0%)
Phase 2Efficacy & side effects
4(33.3%)
Phase 3Large-scale testing
2(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

58.3%

7 of 12 finished

Non-Completion Rate

41.7%

5 ended early

Currently Active

0

trials recruiting

Total Trials

12

all time

Status Distribution
Completed(7)
Terminated(5)

Detailed Status

Completed7
Withdrawn3
Terminated2

Development Timeline

Analytics

Development Status

Total Trials
12
Active
0
Success Rate
77.8%
Most Advanced
Phase 3

Trials by Phase

Phase 16 (50.0%)
Phase 24 (33.3%)
Phase 32 (16.7%)

Trials by Status

withdrawn325%
completed758%
terminated217%

Recent Activity

0 active trials
Showing 5 of 12
withdrawnphase_3

802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

NCT03070132
withdrawnphase_3

802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

NCT03637387
terminatedphase_2

Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

NCT03339336
withdrawnphase_1

Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy

NCT04106050
terminatedphase_2

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074

NCT02957617
View all 12 trials

Clinical Trials (12)

Showing 12 of 12 trials
NCT03070132Phase 3

802NP301 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

Withdrawn
NCT03637387Phase 3

802NP302 Efficacy and Safety Study of BIIB074 in Participants With Trigeminal Neuralgia

Withdrawn
NCT03339336Phase 2

Efficacy and Safety Study of BIIB074 in Participants With Small Fiber Neuropathy

Terminated
NCT04106050Phase 1

Pharmacodynamic Study of BIIB095 and BIIB074 in Healthy Participants and Participants With Painful Diabetic Polyneuropathy

Withdrawn
NCT02957617Phase 2

Extension Study to Evaluate the Long-Term Safety, Tolerability, and Maintenance of Effect of BIIB074

Terminated
NCT03324685Phase 1

A Drug Interaction Study of BIIB074 and an Oral Contraceptive Regimen

Completed
NCT02935608Phase 2

Study to Evaluate the Efficacy and Safety of BIIB074 in Neuropathic Pain From Lumbosacral Radiculopathy

Completed
NCT03385525Phase 1

Study to Evaluate the Effect of UGT Inhibition by Valproic Acid on the Pharmacokinetics of BIIB074

Completed
NCT02917187Phase 2

A Phase 2a Study of BIIB074 in the Treatment of Erythromelalgia

Completed
NCT02831517Phase 1

PK and Safety Study of BIIB074 in Healthy Japanese and Caucasian Participants

Completed
NCT02751905Phase 1

Absorption, Metabolism, and Excretion Study of BIIB074

Completed
NCT02698267Phase 1

Effect of Itraconazole on the Pharmacokinetics of BIIB074

Completed

All 12 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
12